Pentoxifylline is a prescription medication primarily used to treat intermittent claudication, the cramping leg pain that occurs during walking in people with peripheral artery disease. Sold under the brand name Trental, it works by improving blood flow rather than opening blocked arteries directly. It is also used off-label for several other conditions, most notably venous leg ulcers.
How Pentoxifylline Works
Peripheral artery disease narrows the blood vessels in your legs, reducing the oxygen supply to your muscles. Pentoxifylline doesn’t widen those arteries or remove blockages. Instead, it changes the physical properties of your blood so it flows more easily through narrowed passages.
It does this in several ways at once. It makes red blood cells more flexible, allowing them to squeeze through tight spots. It reduces the tendency of red blood cells and platelets to clump together. It also lowers levels of fibrinogen, a protein involved in clotting, which thins the blood’s overall consistency. The combined effect is blood that moves more freely, delivering more oxygen to muscles that aren’t getting enough.
Treating Intermittent Claudication
Intermittent claudication is the primary FDA-approved use. If you have peripheral artery disease and experience aching, cramping, or tiredness in your legs when you walk, pentoxifylline is meant to help you walk farther with less pain. It’s not a replacement for procedures like surgical bypass or stenting when those are needed. It’s a supportive treatment that can improve day-to-day function.
The evidence for how well it works is mixed. A Cochrane review of 17 trials found that the improvement in pain-free walking distance compared to placebo varied enormously, ranging from no meaningful benefit to roughly a 74% improvement. Total walking distance improvements ranged from about 1% to 156%. That wide spread suggests it helps some people significantly and others barely at all, which is worth knowing if you’ve been on it for a while without noticing a difference.
Venous Leg Ulcers
One of the better-supported off-label uses is for venous leg ulcers, the slow-healing wounds that develop on the lower legs when veins don’t return blood efficiently. A meta-analysis of 13 studies covering over 900 patients found that adding pentoxifylline to standard wound care increased the healing rate by about 59% compared to placebo. Ulcers were also more than twice as likely to shrink by over 60% in size. The average time to complete healing was shorter as well.
For this use, the medication typically needs to be continued for at least three months or until the ulcer has fully healed. Stopping too early may mean missing the benefit. The trade-off is a higher rate of stomach-related side effects, which roughly doubled in the studies compared to placebo.
Peyronie’s Disease
Pentoxifylline is sometimes prescribed off-label for Peyronie’s disease, a condition where scar tissue in the penis causes curvature and sometimes pain. It’s thought to work by reducing the buildup of that scar tissue. In practice, it’s often combined with other medications rather than used alone.
A retrospective study of 160 patients treated with a three-drug combination (pentoxifylline plus two other medications) found that about 4% of curvatures resolved completely, another 14% improved, and 45% stayed stable. Roughly 58% of patients who had penile pain at the start experienced relief. These results are modest, but for a condition with limited treatment options in its early phase, the combination approach is considered reasonable by many specialists.
Alcoholic Hepatitis
Pentoxifylline was once widely used for severe alcoholic hepatitis based on earlier studies suggesting it could reduce deaths from kidney failure associated with the condition. However, a large trial published in The New England Journal of Medicine found no survival benefit at 28 days compared to placebo. That study largely ended routine use for this indication, though some clinicians still consider it in specific situations.
Typical Dosage
The standard dose is one 400 mg extended-release tablet taken three times a day with meals. Taking it with food helps reduce stomach upset. If digestive or nervous system side effects become bothersome, the dose can be reduced to twice daily. For people with significantly reduced kidney function, the dose is typically lowered to once daily.
Common Side Effects
The most frequent side effects involve the digestive system: nausea, bloating, and general stomach discomfort. Some people also experience dizziness or headaches. These effects are dose-related, meaning they tend to improve when the dose is lowered. If reducing the dose doesn’t resolve the issue, discontinuing the medication is usually the next step.
Because pentoxifylline affects blood clotting and platelet behavior, it can increase bleeding risk. This is especially relevant if you’re also taking blood thinners or antiplatelet medications. People with recent bleeding events, particularly in the brain or eyes, are generally not candidates for this medication. It also belongs to a chemical family related to caffeine and theophylline, so anyone with a known sensitivity to those compounds should avoid it.
What to Expect on Treatment
Pentoxifylline isn’t a fast-acting medication. Improvements in walking distance for claudication typically take several weeks to become noticeable, and some guidelines suggest giving it at least eight weeks before judging whether it’s working. For venous ulcers, the timeline is even longer, with three months being the minimum recommended treatment period. If you don’t notice any improvement after a reasonable trial, it’s worth discussing alternatives with your prescriber rather than continuing indefinitely.